A detailed history of Org Partners LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Org Partners LLC holds 2,000 shares of SRPT stock, worth $227,440. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,000
Previous 1,700 17.65%
Holding current value
$227,440
Previous $212,000 14.62%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$104.54 - $137.94 $31,362 - $41,382
300 Added 17.65%
2,000 $243,000
Q2 2024

Jul 16, 2024

BUY
$113.33 - $163.85 $192,661 - $278,545
1,700 New
1,700 $268,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.96B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.